1
Chronic Respiratory Disease Research Center ( CRDRC ), National Research Institute of Tuberculosis and Lung Disease ( NRITLD ), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Telemedicine Research Center of Masih Daneshvari Hospital, Chronic Kidney Disease Research Center, Shahid Beheshti university of Medical Sciences, Tehran, Iran
3
Pediatric Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease ( NRITLD ), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Yassari,F , Mirenayat,M S , Fakharian,A , Rashid-Farokhi,F and Honarpisheh,P . (2023). Remdesivir in Patients with Advanced Renal Failure and COVID-19. TANAFFOS (Respiration), 22(3), 276-278.
MLA
Yassari,F , , Mirenayat,M S , , Fakharian,A , , Rashid-Farokhi,F , and Honarpisheh,P . "Remdesivir in Patients with Advanced Renal Failure and COVID-19", TANAFFOS (Respiration), 22, 3, 2023, 276-278.
HARVARD
Yassari F, Mirenayat M S, Fakharian A, Rashid-Farokhi F, Honarpisheh P. (2023). 'Remdesivir in Patients with Advanced Renal Failure and COVID-19', TANAFFOS (Respiration), 22(3), pp. 276-278.
CHICAGO
F Yassari, M S Mirenayat, A Fakharian, F Rashid-Farokhi and P Honarpisheh, "Remdesivir in Patients with Advanced Renal Failure and COVID-19," TANAFFOS (Respiration), 22 3 (2023): 276-278,
VANCOUVER
Yassari F, Mirenayat M S, Fakharian A, Rashid-Farokhi F, Honarpisheh P. Remdesivir in Patients with Advanced Renal Failure and COVID-19. TANAFFOS (Respiration). 2023;22(3):276-278.
